Stay updated on Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page.

Latest updates to the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded Squamous cell carcinoma of the head and neck and Small cell lung carcinoma to the list of conditions. Added Genetic and Rare Diseases Information Center as a related resources reference.SummaryDifference0.1%

- Check26 days agoChange DetectedAdded Naples, Italy (80131) as a study site and updated the city name from Napoli to Naples.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page shows a minor site version update with Revision: v3.4.2 added and Revision: v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page documentation.SummaryDifference0.0%

Stay in the know with updates to Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page.